Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk
Prevalence of Atherosclerotic Carotid and/or Femoral Plaques in Patients Without Known Cardiovascular Disease and at Low-risk for Major Cardiovascular Events (AGLA/GLSA Score) Visiting a Private Primary Healthcare Practice in Switzerland
1 other identifier
observational
22
0 countries
N/A
Brief Summary
Cardiovascular disease is a common diagnosed and treated condition in private practices of primary health care. There is growing evidence that atherosclerotic plaques as predictors for stroke and heart attack are more prevalent than expected based on the clinical score in people with low risk for stroke and heart attack . Diagnosing atherosclerotic plaques can help to decide if a lipid lowering therapy should be prescribed even if the clinical risk score is low or on the other hand if they can be observed even in high lipid levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2016
CompletedFirst Submitted
Initial submission to the registry
March 22, 2018
CompletedFirst Posted
Study publicly available on registry
April 17, 2018
CompletedApril 17, 2018
April 1, 2018
8 months
March 22, 2018
April 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of plaques in cardiovascular low risk population
Number of participants with the presence of carotid and/or femoral atherosclerotic plaques diagnosed via ultrasound (defined as a focal intima-media thickness \>0.5 cm on ultrasound).
1 year
Interventions
screening by ultrasound of atherosclerotic plaques
Eligibility Criteria
The carotid and femoral arteries of 22 asymptomatic patients (9 females,13 males) aged between 41-72 having a low cardiovascular risk score based on blood pressure, nicotine abuse history, cardiac family history, blood analysis in fasting state for diabetes, lipid status including total cholesterol HDL-cholesterol, triglycerides and calculated LDL-cholesterol were screened by ultrasound.
You may qualify if:
- low cardiovascular risk assessed by the AGLA/GSLA-score
You may not qualify if:
- cardiovascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Demetrio A Pitarch, MD
Cabinet de medecine generale
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2018
First Posted
April 17, 2018
Study Start
January 15, 2016
Primary Completion
August 30, 2016
Study Completion
September 4, 2016
Last Updated
April 17, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share